listed · IPO · BSE/NSE · listed 2 April 2026

Sai Parenteral's Limited

at ₹392 per share.

+3.7%

listing-day move

Price band

₹372 – ₹392

Issue price

₹392

Listing-day close

₹406.4

Return since listing

+23.95%

Company research

Source: Tijori Finance · third-party enrichment

About the company

Sai Parenteral’s Limited is a Hyderabad-based pharmaceutical company engaged in the development, manufacturing, and distribution of parenteral formulations. Established in 2001, it operates WHO-GMP certified facilities and offers injectables and other dosage forms, serving domestic and global markets.

Financials (₹ crore)

Period	Revenue	PAT	Debt
Mar 2023	96.8 Cr	4.38 Cr	68.55 Cr
Mar 2024	153.76 Cr	8.89 Cr	118.78 Cr
Mar 2025	163.11 Cr	14.2 Cr	93.95 Cr

Revenue mix

Branded Generic Formulations 72.0%

CDMO 28.0%

Peer comparison

Company	Mkt cap (Cr)	Revenue	PAT	P/E	P/B
SAIPARENT	2,142	163 Cr	14.2 Cr	150.19	4.36
SAILIFE	23,983	1,694 Cr	170 Cr	68.74	9.66
INNOVACAP	4,851	1,243 Cr	128 Cr	34.42	4.45
SENORES	5,129	398 Cr	58.56 Cr	44.46	5.49
GLAND	38,113	5,616 Cr	698 Cr	37.1	3.68

Exchange filings

Fields captured from NSE and BSE

Issue information

Symbol: SAIPARENT
Issue period: 2026-03-24 to 2026-03-27
Price range: Rs.372 to Rs.392
DRHP: https://www.bseindia.com/downloads/ipo/367498/IPO%20Prior/DRHP_20250930232833.pdf
Red Herring Prospectus: https://www.bseindia.com/downloads/ipo/367498/IPO%20Open/6RHPSigned_20260320185734.pdf
Prospectus: https://www.bseindia.com/downloads/ipo/367498/IPO%20BasisOfAllotment/Sai%20Parenterals_Prospectus_20260330110546.pdf

Data sources: BSE , BSE , NSE , YAHOO . Data quality clean.